Business Medical Dialogues
    • facebook
    • twitter
    Sign in Signup
    • facebook
    • twitter
    Sign in Signup
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    Sign InRegister
    Business Medical Dialogues
    Sign inRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • ebitda

    Tag: ebitda

    You Searched For "ebitda"
    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Medical Dialogues Bureau20 Nov 2019 4:00 AM GMT
    Suven Life Sciences provides contract research and manufacturing services to global life sciences companies. It plans to invest 75 million dollars (abo...
    GSK Pharma reports Q2 profit at Rs 503 crore

    GSK Pharma reports Q2 profit at Rs 503 crore

    Medical Dialogues Bureau1 Nov 2019 3:45 AM GMT
    GSK Pharmaceuticals continues to drive improved operational efficiencies reflecting in earnings before interest, tax, depreciation and amortisation (EB...
    GSK sells 6 brands including Savlon antiseptic cream to Stada Pharma

    GSK sells 6 brands including Savlon antiseptic cream to Stada Pharma

    Medical Dialogues Bureau8 Jun 2019 4:30 AM GMT
    The price tag for the mainly Europe-focused brand portfolio, which includes itch relief cream Eurax, antiseptic cream Savlon and Tixylix cough liquids,...
    Currency headwinds quell drug gains in Q4; says Merck KGaA

    Currency headwinds quell drug gains in Q4; says Merck KGaA

    Garima10 March 2019 3:29 AM GMT
    FRANKFURT: Germany's Merck KGaA posted a 1.3 per cent decline in adjusted core earnings in the fourth quarter as negative currency effects more than...
    Aster DM Healthcare to focus on Expansion in South, West India, to invest Rs 650 crore: Report

    Aster DM Healthcare to focus on Expansion in South, West India, to invest Rs 650 crore: Report

    Farhat Nasim21 Jan 2019 8:43 AM GMT
    'Our idea is to focus only on tertiary care in cities and we are exploring new facilities in Mumbai, Pune and in Thiruvananthapuram, where we have purc...
    Pharma sector earnings to remain muted in Dec quarter: Edelweiss Securities

    Pharma sector earnings to remain muted in Dec quarter: Edelweiss Securities

    Ruby Khatun Khatun7 Jan 2018 4:30 AM GMT
    New Delhi: Pharma sector's December quarter revenue is estimated to remain flat, while profits are likely to slip owing to decline in US businesses...
    Fortis Healthcare rejects over pricing of drugs charge

    Fortis Healthcare rejects over pricing of drugs charge

    Ruby Khatun Khatun18 Dec 2017 5:30 AM GMT
    New Delhi: Fortis Healthcare has rejected charges of overpricing the medicines that it is giving to its patients.In a statement, it said, 'Fortis...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 29 March 2022 11:15 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
    verify here.

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok
    X
    X